Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation
Using a simple mathematical model, this paper found there is limited evidence and much uncertainty in relation to the clinical effectiveness and cost-effectiveness of enzyme-linked immunosorbent assay test-based therapeutic drug monitoring in rheumatoid arthritis.
Source:
National Institute for Health Research